C10orf62
gene geneOn this page
Also known as bA548K23.1
Summary
C10orf62 (chromosome 10 open reading frame 62, HGNC:23294) is a protein-coding gene on chromosome 10q24.2, encoding Uncharacterized protein C10orf62 (Q5T681).
At a glance
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_001009997
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23294 |
| Approved symbol | C10orf62 |
| Name | chromosome 10 open reading frame 62 |
| Location | 10q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA548K23.1 |
| Ensembl gene | ENSG00000203942 |
| Ensembl biotype | protein_coding |
| Entrez | 414157 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000370640
RefSeq mRNA: 1 — MANE Select: NM_001009997
NM_001009997
CCDS: CCDS31261
Canonical transcript exons
ENST00000370640 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001453205 | 97589721 | 97590934 |
Expression profiles
Bgee: expression breadth broad, 97 present calls, max score 98.14.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2882 / max 263.8847, expressed in 5 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 106451 | 0.2701 | 5 |
| 106450 | 0.0181 | 4 |
Top tissues by expression
226 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 98.14 | gold quality |
| right testis | UBERON:0004534 | 98.10 | gold quality |
| sperm | CL:0000019 | 96.94 | gold quality |
| testis | UBERON:0000473 | 94.91 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.90 | gold quality |
| adult organism | UBERON:0007023 | 81.07 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 75.76 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 75.62 | gold quality |
| kidney epithelium | UBERON:0004819 | 68.41 | gold quality |
| tibialis anterior | UBERON:0001385 | 67.24 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 64.85 | gold quality |
| pancreatic ductal cell | CL:0002079 | 64.79 | silver quality |
| quadriceps femoris | UBERON:0001377 | 63.26 | gold quality |
| deltoid | UBERON:0001476 | 62.45 | gold quality |
| vastus lateralis | UBERON:0001379 | 61.91 | gold quality |
| myocardium | UBERON:0002349 | 61.61 | gold quality |
| apex of heart | UBERON:0002098 | 60.79 | gold quality |
| cartilage tissue | UBERON:0002418 | 60.08 | gold quality |
| cauda epididymis | UBERON:0004360 | 60.08 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 58.29 | gold quality |
| superficial temporal artery | UBERON:0001614 | 57.75 | gold quality |
| heart left ventricle | UBERON:0002084 | 57.51 | gold quality |
| cardiac ventricle | UBERON:0002082 | 57.32 | gold quality |
| oocyte | CL:0000023 | 56.21 | gold quality |
| right lobe of liver | UBERON:0001114 | 55.98 | gold quality |
| parotid gland | UBERON:0001831 | 55.37 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 55.23 | gold quality |
| heart right ventricle | UBERON:0002080 | 55.01 | gold quality |
| corpus epididymis | UBERON:0004359 | 54.72 | gold quality |
| endothelial cell | CL:0000115 | 54.46 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 4267.27 |
| E-ANND-3 | no | 0.29 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
21 targeting C10orf62, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-3913-3P | 99.74 | 66.53 | 938 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-6740-3P | 99.48 | 68.49 | 1392 |
| HSA-MIR-942-5P | 99.41 | 68.40 | 1977 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-6815-3P | 99.13 | 68.98 | 1530 |
| HSA-MIR-4742-5P | 98.89 | 68.41 | 1542 |
| HSA-MIR-6784-3P | 98.39 | 64.88 | 662 |
| HSA-MIR-6862-3P | 97.92 | 64.86 | 531 |
| HSA-MIR-8057 | 97.64 | 66.54 | 897 |
| HSA-MIR-6849-3P | 97.25 | 64.57 | 1371 |
| HSA-MIR-874-5P | 96.93 | 63.92 | 1014 |
| HSA-MIR-3194-5P | 96.80 | 64.90 | 1027 |
| HSA-MIR-6858-3P | 96.37 | 64.41 | 771 |
| HSA-MIR-6815-5P | 96.05 | 65.55 | 662 |
| HSA-MIR-6865-5P | 96.05 | 65.58 | 675 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | 4933411K16Rik | ENSMUSG00000090369 |
| rattus_norvegicus | MGC93861 | ENSRNOG00000069762 |
Protein
Protein identifiers
Uncharacterized protein C10orf62 — Q5T681 (reviewed: Q5T681)
All UniProt accessions (1): Q5T681
RefSeq proteins (1): NP_001009997* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR037649 | C10orf62 | Family |
Pfam: PF17729
UniProt features (11 total): compositionally biased region 5, region of interest 3, chain 1, sequence variant 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5T681-F1 | 61.32 | 0.01 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 43
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 12 (showing top):
MIR6740_3P, MIR4673, MIR3194_5P, GSE13306_RA_VS_UNTREATED_TREG_UP, GSE14026_TH1_VS_TH17_UP, GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN, GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP, chr10q24, GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP, GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_UP, GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP, GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
762 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C10orf62 | CFAP141 | Q5VU69 | 651 |
| C10orf62 | OR5M3 | Q8NGP4 | 604 |
| C10orf62 | ZNF285 | Q96NJ3 | 583 |
| C10orf62 | XAGE5 | Q8WWM1 | 576 |
| C10orf62 | ARMCX6 | Q7L4S7 | 574 |
| C10orf62 | DRG1 | Q9Y295 | 479 |
| C10orf62 | TRAPPC6B | Q86SZ2 | 470 |
| C10orf62 | SLC12A9 | Q9BXP2 | 450 |
| C10orf62 | PASK | Q96RG2 | 450 |
| C10orf62 | REC114 | Q7Z4M0 | 446 |
| C10orf62 | NIBAN3 | Q86XR2 | 433 |
| C10orf62 | ARHGAP11B | Q3KRB8 | 398 |
| C10orf62 | CDK17 | Q00537 | 371 |
| C10orf62 | CST1 | P01037 | 370 |
| C10orf62 | RNF185 | Q96GF1 | 370 |
IntAct
39 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| C10orf62 | MDFI | psi-mi:“MI:0915”(physical association) | 0.820 |
| MDFI | C10orf62 | psi-mi:“MI:0915”(physical association) | 0.820 |
| FXR2 | C10orf62 | psi-mi:“MI:0915”(physical association) | 0.670 |
| C10orf62 | FXR2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| C10orf62 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KRTAP5-9 | C10orf62 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C10orf62 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C10orf62 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C10orf62 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| C10orf62 | KRTAP5-9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | C10orf62 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | C10orf62 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAF3 | C10orf62 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-8 | C10orf62 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-1 | C10orf62 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C10orf62 | PFDN5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C10orf62 | KRTAP4-12 | psi-mi:“MI:0915”(physical association) | 0.370 |
| C10orf62 | PLSCR1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| FAM50A | C10orf62 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (18): C10orf62 (Two-hybrid), C10orf62 (Two-hybrid), C10orf62 (Two-hybrid), C10orf62 (Two-hybrid), C10orf62 (Two-hybrid), C10orf62 (Two-hybrid), C10orf62 (Two-hybrid), C10orf62 (Two-hybrid), C10orf62 (Two-hybrid), C10orf62 (Two-hybrid), C10orf62 (Two-hybrid), C10orf62 (Two-hybrid), C10orf62 (Two-hybrid), C10orf62 (Two-hybrid), C10orf62 (Affinity Capture-MS)
ESM2 similar proteins: A0A023PZB3, A0A0D1C8C8, A0A182BSS2, A6ZT44, A6ZTA1, B3P309, B8QCG6, F2Z472, K9N4Q4, P04812, P0CA75, P0CJ15, P0CV29, P0DMD1, P0DQF2, P19815, P21739, P23498, P28549, P32772, P34646, P38839, P38881, P39035, P80195, P92528, Q02596, Q03556, Q04807, Q07967, Q09221, Q09953, Q23262, Q3SZQ3, Q4V7B4, Q4VKV7, Q59Y11, Q5H7N6, Q5T681, Q5UP16
Diamond homologs: Q5T681, Q6AYN3, Q80Y39
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
197 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:97590629:G:GT | donor_gain | 0.6900 |
| 10:97590661:ATG:A | acceptor_gain | 0.6900 |
| 10:97590662:T:TA | acceptor_gain | 0.6800 |
| 10:97590874:C:T | donor_gain | 0.6800 |
| 10:97590661:AT:A | acceptor_gain | 0.6700 |
| 10:97590681:CAGGG:C | donor_loss | 0.6700 |
| 10:97590684:GGTGA:G | donor_loss | 0.6700 |
| 10:97590685:G:GA | donor_loss | 0.6700 |
| 10:97590686:T:A | donor_loss | 0.6700 |
| 10:97590683:GG:G | donor_gain | 0.6600 |
| 10:97590684:GG:G | donor_gain | 0.6600 |
| 10:97590414:G:GT | donor_gain | 0.6500 |
| 10:97590418:T:TA | donor_gain | 0.6500 |
| 10:97590419:A:AA | donor_gain | 0.6500 |
| 10:97590662:T:G | acceptor_gain | 0.6500 |
| 10:97590663:G:A | acceptor_gain | 0.6500 |
| 10:97590687:G:GT | donor_loss | 0.6400 |
| 10:97590256:A:G | donor_gain | 0.6200 |
| 10:97590625:C:T | donor_gain | 0.6200 |
| 10:97590630:C:T | donor_gain | 0.6200 |
| 10:97590685:G:GG | donor_gain | 0.6100 |
| 10:97590647:C:A | donor_gain | 0.6000 |
| 10:97590689:G:C | donor_loss | 0.5800 |
| 10:97590644:C:G | donor_gain | 0.5700 |
| 10:97590689:G:GT | donor_gain | 0.5600 |
| 10:97590688:A:G | donor_loss | 0.5500 |
| 10:97590365:TCACC:T | donor_gain | 0.5400 |
| 10:97590585:G:GT | donor_gain | 0.5400 |
| 10:97590754:T:G | acceptor_gain | 0.5400 |
| 10:97590504:A:AG | acceptor_gain | 0.5300 |
AlphaMissense
1489 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:97590012:T:C | F39L | 0.989 |
| 10:97590014:T:A | F39L | 0.989 |
| 10:97590014:T:G | F39L | 0.989 |
| 10:97590013:T:C | F39S | 0.979 |
| 10:97589997:T:A | W34R | 0.974 |
| 10:97589997:T:C | W34R | 0.974 |
| 10:97590001:T:C | I35T | 0.973 |
| 10:97589999:G:C | W34C | 0.971 |
| 10:97589999:G:T | W34C | 0.971 |
| 10:97590015:A:C | S40R | 0.965 |
| 10:97590017:C:A | S40R | 0.965 |
| 10:97590017:C:G | S40R | 0.965 |
| 10:97590309:G:T | G138W | 0.965 |
| 10:97590430:T:C | L178P | 0.962 |
| 10:97590009:C:G | H38D | 0.961 |
| 10:97590001:T:G | I35S | 0.956 |
| 10:97590309:G:A | G138R | 0.956 |
| 10:97590309:G:C | G138R | 0.956 |
| 10:97590319:T:C | L141P | 0.955 |
| 10:97590005:A:C | K36N | 0.953 |
| 10:97590005:A:T | K36N | 0.953 |
| 10:97590011:C:A | H38Q | 0.949 |
| 10:97590011:C:G | H38Q | 0.949 |
| 10:97590321:G:C | A142P | 0.948 |
| 10:97590013:T:G | F39C | 0.947 |
| 10:97590400:T:C | L168P | 0.947 |
| 10:97590409:T:C | L171P | 0.943 |
| 10:97590269:G:C | W124C | 0.940 |
| 10:97590269:G:T | W124C | 0.940 |
| 10:97590322:C:A | A142D | 0.933 |
dbSNP variants (sampled 300 via entrez): RS1000194610 (10:97591148 T>A), RS1002456222 (10:97588546 T>C), RS1003075808 (10:97588983 G>GC), RS1005180264 (10:97590869 G>T), RS1005276865 (10:97590641 A>G), RS1007084345 (10:97591137 C>T), RS1007142595 (10:97590931 T>A,C), RS1007524706 (10:97589544 G>T), RS1007575292 (10:97589236 T>A), RS1008582700 (10:97588059 G>A), RS1008930676 (10:97588195 CTTTCTTTTTT>C), RS1012482351 (10:97590302 C>A), RS1012895434 (10:97590306 CA>C), RS1013488475 (10:97588864 G>A), RS1015537354 (10:97588875 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.